Skip to main content

Part of cannabis and small business and retail

Demand for private-equity investments in the cannabis sector remains high as Canada’s legalization of recreational marijuana approaches, says the head of a firm that has just launched a second venture capital fund.

Calgary-based Green Acre Capital has received commitments of $35-million from the likes of major cannabis producer Aphria Inc., financier and Green Acre adviser Brett Wilson and Saskatchewan cannabis funding firm York Plains Investment Corp.

Aphria is the largest contributor, committing $15-million. Its chief executive officer, Vic Neufeld, is on Green Acre’s advisory board.

Story continues below advertisement

Green Acre’s first fund invested $25-million in 12 companies, with a focus on small firms offering ancillary products and services, such as cultivation technology, software and retail brands, notably Tokyo Smoke.

“The cultivation side is a challenging, competitive market, and what we observe in the legal U.S. states is that the pricing of cannabis tends to drop pretty sharply in those competitive markets,” said Green Acre managing director Tyler Stuart. “So we decided to focus on all of the infrastructure around those growers. We found there’s a lot of opportunity, and the valuations are quite good.”

In addition, there is less competition for such investments, Mr. Stuart said.

Private-equity firms are expanding in the cannabis sector, seeking opportunities outside the volatile public markets, in which financing and takeover activity has been at a fever pitch in anticipation of the Oct. 17 legalization of recreational marijuana in Canada.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter